Skip to main content
. 2021 Sep 25;22(19):10323. doi: 10.3390/ijms221910323

Table 1.

Classification and clinical uses of biomarkers.

Biomarkers Description
Predictive Risk to Develop MS
Diagnostic Fast Interpretation of Pathological State of MS
Prognosis Outcome or Course of MS
Disease-Associated Activity Demonstration of Current MS Condition as Inflammation, Demyelination, Cognitive Dysfunction, etc.
Response to Treatment Predict Response to Therapy in MS Patients